O2 Closes 4th Dental Lab Add-On
Search

O2 Closes 4th Dental Lab Add-On

With the buy of D&S, Frontier Dental Lab Group now has just over 605 employees and operates ten laboratories under five brands in California (2), Wisconsin (5), Illinois, New York, and  Canada

Frontier Dental Lab Group is a provider of general dentistry and cosmetic dentistry products including crowns, bridges, veneers, implants, dentures and nightguards

SOURCE: Getty Images

Frontier Dental Lab Group, a portfolio company of O2 Investment Partners, has acquired D&S Dental Laboratory.

D&S Dental is a provider of general dentistry and cosmetic dentistry products. The company has approximately 125 employees and is headquartered near Madison in Waunakee, Wisconsin, with four additional laboratories in Wisconsin (3) and Illinois.

[Source: Frontier Dental Lab Group]
Frontier Dental Lab (FDL) is a full-service, multi-site laboratory group that provides dental prosthetics for cosmetic dentistry (anterior crowns and bridges, and veneers), general dentistry (posterior crowns and bridges), implants, and other removable dental products (dentures and nightguards). FDL is headquartered near Sacramento in El Dorado Hills, California.

“D&S has a rich history of nearly 50 years of excellence, and we could not be more thrilled to add them to the platform,” said Jimmy Frye, a vice president at O2. “Alongside NuArt, the partnership with D&S further strengthens the platforms Midwest presence.”

O2 acquired FDL in July 2019 in partnership with the company’s owners and senior management team led by President Brent West and VP Sales Gil Villavecer. At acquisition, the company operated two dental laboratories, one each in California and British Columbia.

In addition to the buy of D&S, FDL has acquired three other dental labs including Wisconsin-based NuArt Dental (October 2019), California-based Burbank Dental Laboratory (March 2022), and New York-based Dental Lab Aesthetics (May 2022).

Today, with the close of the buy of D&S, FDL now has just over 605 employees and operates ten laboratories under five brands in California (2), Wisconsin (5), Illinois, New York, and  Canada.

O2 makes control investments in companies with EBITDA of more than $5 million located anywhere in the United States and Canada but with a preference for the Midwest and the Great Lakes regions. The firm’s typical transaction size is $15 million to $50 million. Industries of interest include manufacturing, niche distribution, select service and technology businesses. O2 is based in the Detroit suburb of Bloomfield Hills, Michigan.

© 2022 Private Equity Professional | August 9, 2022

To search in site, type your keyword and hit enter